Enovis Total Long-Term Assets 2010-2024 | ENOV
Enovis Annual Total Long-Term Assets (Millions of US $) |
|
---|---|
2023 | $3,613 |
2022 | $3,478 |
2021 | $6,213 |
2020 | $5,990 |
2019 | $5,983 |
2018 | $4,658 |
2017 | $4,640 |
2016 | $4,600 |
2015 | $5,002 |
2014 | $5,137 |
2013 | $4,469 |
2012 | $4,017 |
2011 | $737 |
2010 | $701 |
2009 | $709 |
Enovis Quarterly Total Long-Term Assets (Millions of US $) |
|
---|---|
2024-06-30 | $4,269 |
2024-03-31 | $4,328 |
2023-12-31 | $3,613 |
2023-09-30 | $3,547 |
2023-06-30 | $3,556 |
2023-03-31 | $3,466 |
2022-12-31 | $3,478 |
2022-09-30 | $3,437 |
2022-06-30 | $3,426 |
2022-03-31 | $6,136 |
2021-12-31 | $6,213 |
2021-09-30 | $6,247 |
2021-06-30 | $6,081 |
2021-03-31 | $5,989 |
2020-12-31 | $5,990 |
2020-09-30 | $5,867 |
2020-06-30 | $5,894 |
2020-03-31 | $5,874 |
2019-12-31 | $5,983 |
2019-09-30 | $6,092 |
2019-06-30 | $6,263 |
2019-03-31 | $8,094 |
2018-12-31 | $4,658 |
2018-09-30 | $4,495 |
2018-06-30 | $4,515 |
2018-03-31 | $4,716 |
2017-12-31 | $4,640 |
2017-09-30 | $4,523 |
2017-06-30 | $4,772 |
2017-03-31 | $4,649 |
2016-12-31 | $4,600 |
2016-09-30 | $4,739 |
2016-06-30 | $4,789 |
2016-03-31 | $4,939 |
2015-12-31 | $5,002 |
2015-09-30 | $5,041 |
2015-06-30 | $5,005 |
2015-03-31 | $4,923 |
2014-12-31 | $5,137 |
2014-09-30 | $5,311 |
2014-06-30 | $5,517 |
2014-03-31 | $4,429 |
2013-12-31 | $4,469 |
2013-09-30 | $3,967 |
2013-06-30 | $3,807 |
2013-03-31 | $3,860 |
2012-12-31 | $4,017 |
2012-09-30 | $3,822 |
2012-06-30 | $3,709 |
2012-03-31 | $3,792 |
2011-12-31 | $737 |
2011-09-30 | $694 |
2011-06-30 | $721 |
2011-03-31 | $728 |
2010-12-31 | $701 |
2010-09-30 | $719 |
2010-06-30 | $686 |
2010-03-31 | $705 |
2009-12-31 | $709 |
2009-09-30 | $717 |
2009-06-30 | $610 |
2009-03-31 | $606 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $2.437B | $1.707B |
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $40.428B | 21.75 |
Tempus AI (TEM) | United States | $7.918B | 0.00 |
Inspire Medical Systems (INSP) | United States | $6.215B | 1157.72 |
Axonics (AXNX) | United States | $3.513B | 0.00 |
Hims & Hers Health (HIMS) | United States | $3.503B | 203.88 |
10x Genomics (TXG) | United States | $2.660B | 0.00 |
Azenta (AZTA) | United States | $2.413B | 137.03 |
Privia Health (PRVA) | United States | $2.280B | 158.92 |
IRhythm Technologies (IRTC) | United States | $2.219B | 0.00 |
Omnicell (OMCL) | United States | $1.968B | 64.82 |
Clover Health Investments (CLOV) | United States | $1.492B | 0.00 |
Schrodinger (SDGR) | United States | $1.436B | 0.00 |
Phreesia (PHR) | United States | $1.389B | 0.00 |
Standard BioTools (LAB) | United States | $0.753B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.694B | 0.00 |
Definitive Healthcare (DH) | United States | $0.538B | 456.00 |
Health Catalyst (HCAT) | United States | $0.529B | 0.00 |
Butterfly Network (BFLY) | United States | $0.406B | 0.00 |
Talkspace (TALK) | United States | $0.343B | 0.00 |
Pulmonx (LUNG) | United States | $0.329B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.286B | 0.00 |
TruBridge (TBRG) | United States | $0.183B | 13.44 |
P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
American Well (AMWL) | United States | $0.147B | 0.00 |
Augmedix (AUGX) | United States | $0.115B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.055B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
111 (YI) | China | $0.051B | 0.00 |
Zepp Health (ZEPP) | China | $0.049B | 0.00 |
CareCloud (CCLD) | United States | $0.045B | 0.00 |
Movano (MOVE) | United States | $0.036B | 0.00 |
Outset Medical (OM) | United States | $0.034B | 0.00 |
MSP Recovery (LIFW) | United States | $0.025B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Syra Health (SYRA) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |